S u m m a r y Polyomavirus (PyV) infection of SCID mice, which lack functional T and B cells, leads to a lethal acute myeloproliferative disease (AMD) and to high levels of virus replication in several organs by two wk after infection. This is in contrast to infection o f T cell-deficient athymic nude mice, which are resistant to acute PyV-induced disease and poorly replicate the virus in their organs. This major difference in the virus load and in the outcome of PyV infection between SCID and nude mice suggested that an efficient, T cell-independent antiviral mechanism operates in T cell-deficient, PyV-infected mice. To investigate this possibility, mice with different genetically engineered T and/or B cell deficiencies and SCID mice adoptively reconstituted with B and/or T cells were infected with PyV. The results indicated that the presence of B cells in the absence of T cells protected mice from the AMD, and this was accompanied by a major reduction of PyV in all organs tested. Sera from PyV-infected T cell receptor (TCIK) e~[3 knockout or T C R ot[3 ~/8 knockout mice contained IgG2a antibodies to PyV. Sera or purified immunoglobulin fractions from PyV-infected T C R oq3 knockout mice protected SCID mice from the PyV-induced AMD. To our knowledge, this is the first report of an effective T cellindependent antibody response clearing a virus and changing the outcome of infection from 100% mortality to 100% survival.
V
irus-specific T cells usually play a major role in the process of recovery from acute virus infections (1) . After an early phase of the infection, when nonspecific factors such as N K cells contribute to decreasing the virus load (2), MHC-restricted cytotoxic T cells locate and destroy virusinfected target cells. T cells also secrete cytokines, which further impair virus replication and participate in several aspects of the immune response (3) . For the generation of a high-affinity antibody response and for efficient isotype switching from IgM to IgG and IgA production, T cell help is believed to be essential (4--4) . In some virus infections, such as vesicular stomatitis virus (VSV) 1, reovirus, and Sindbis virus, humoral immunity in the presence of T cells can play a significant role in the control of infection (7) (8) (9) . O f interest is that athymic nude mice can clear intracerebral Sindbis virus infection similarly to immunocompetent mice, suggesting that a T cell-independent immune response may restrict the replication of this pathogen (10, 11) . Nude mice, however, are not completely free of T cells, and a role for T cells or T cell-dependent antibodies could not be excluded in those experiments. Efficient 1Abbreviations used in this paper." AMD, acute mydoproliferative disease; LCMV, lymphocytic choriomeningitis virus; PyV, polyomavirus; VSV, vesicular stomatis virus.
control of an acute virus infection by antibodies produced in the absence o f T cells has therefore not been shown.
Recent developments in immunology, using mice with targeted disruption (knockout) of certain genes, show that there are many redundancies in the immune system. Mice defective in gene products shown to be important for control of infections often can clear viruses or parasites with unexpected efficiency. For example, in mice defective in CD8 + T cells, virus infections known to be controlled by CD8 + CTL were cleared by compensating CD4 + T cells (12, 13) . A potent anti-lymphocytic choriomeningitis virus (LCMV) T cell response and VSV clearance in IFN-~/receptor knockout mice (14) ; detectable CTL responses to LCMV infection in IL-2 knockout mice (15) , and the control ofleishmaniasis in CD4 knockout mice (16) are further examples. This rePort shows that although T cells in the absence of B cells can provide full protection against polyomavirus (PyV) infection in mice, B cells can also clear PyV in a completely T cell-independent fashion, supporting the view that the immune system has components with overlapping functions, and providing the first unambiguous example of a protective T cell-independent antiviral antibody response.
PyV induces a lethal acute myeloproliferative disease (AMD) in SCID mice that lack functional T and B cells (17) . This observation is surprising since hematological disorders are not part of the disease spectrum caused by PyV infection in normal newborn or in T cell-deficient nude mice (18, 19) . Moreover, the A M D in SCID mice is associated with high levels of PyV replication on day 14 after infection in all major organs tested, whereas in nude mice virus replication cannot be detected in most organs at this time (17, 20, 21) . This enhanced virus replication and virus-induced pathology in SCID versus nude mice suggest that an alternative mechanism of PyV clearance is operating in mice deficient in T cells. Here we demonstrate that PyV infection induces virus-specific IgM and IgG production by B cells in the absence o f T cell (and N K cell) help, and that this antibody response can clear PyV and protect T celldeficient mice from the acute lethal myeloproliferative disease caused by the virus.
Materials and Methods
Mice and Virus Infection. C57BL/6JSz SCID mice, 129 TCR c~13"y8-/-mice, which had a targeted disruption in their TCR 13 and 8 genes (22) and therefore lacked functional cq3 and "y8 T cells, 129• I x -/ -mice, which had no functional B cells (23) , 129XC57BL/6 and BALB/c mice were obtained from The Jackson Laboratory (Bar Harbor, ME). 129• TCR c~13-/-mice, which had a targeted disruption of the T C R c~ or 13 gene (24) , and therefore had no functional o~13 T cells, had been backcrossed three-to-four times to C57BL/6. The TCtL o~13-/-(initially from Drs. P. Mombaerts and S. Tonegawa, Massachusetts Institute of Technology, Cambridge, MA) and C.B17 SCID mice were bred in the Department of Animal Medicine of the University of Massachusetts Medical Center, and were housed in microisolator cages in this facility. Mice to be infected were inoculated intraperitoneaily with 2 • 105-2 • 106 50% tissue culture infectious dose (TCID50) of PyV strain A2, provided by Dr. Michele M. Fluck (Michigan State University, East Lansing, MI).
In Vivo NK or T Cell Depletion. Mice with the C57BL/6 background, which express the NKI.1 alloantigen, were depleted of NK cells by i.p. injection with 20-100 IX1 of previously determined optimal dilutions of ammonium sulfate cuts of ascites preparations of a rnonoclonal antibody to NKI.1 (25) . C.B17 SCID mice and TCR ~13~/~-/-mice, which do not express the NKI.1 alloantigen, were depleted of NK cells by an i.p. injection of 10 IXl of antiserum to asialo GM1 (Wako Chemicals USA, Dallas, TX). The anti-NKl.1 or asialo GM1 injections were repeated weekly. The effectiveness of NK cell depletion was tested by using splenocytes of the depleted mice in cytotoxicity assays with 51chromium-labeled conventional NK target cells (YAC-1) in vitro.
CD4+ and CD8+ T cells were depleted in vivo by i.p. injection of 80 txl of an ascites preparation of a rat anti-mouse CD4 rnonoclonal antibody (clone GK1.5 [26] ), and of 150 Ixl of a 1:10 dilution of an ascites preparation of a rat anti-mouse CD8 monoclonal antibody (clone 2.43 [27] ), respectively. The injections were repeated every 6-7 d. The effectiveness of depletion was tested by FACS | (Becton Dickinson Co., Mountain View, CA) staining of peripheral blood leukocytes of killed mice, and these samples were found to be 98-99% free of CD4 + and CD8 + T cells.
Adoptive Transfer Experiments. Spleens harvested from mice
were ground between the frosted ends of glass microscope slides; the resulting cell suspension was filtered through a nylon mesh and treated with 0.83% NH4C1 to remove erythrocytes. Cells prepared from two-to-three spleens (with or without in vitro T cell depletion) were suspended in 650 ILl PBS; 200 IXl of this spleen cell suspension per mouse was given intravenously into C.B17 SCID mice. The adoptive transfer of cells was performed 1 d before the infection of the mice intraperitoneally with 2 • 10 s TCIDs0 units of PyV strain A2.
In Vitro T Cell Depletion. Depletion of CD4 + and CD8 + T cells in spleen cell preparations in vitro was performed by treating the cells with rat anti-mouse Thy-1 monoclonal antibody (clone J1J.10 rat ascites preparation [28] ; l:50 dilution, 150 IXl/107 cells) on ice for 45 rain, washing them twice with PBS, adding 25 IXl/ 107 cells of guinea pig serum as a complement source, and then incubating the cells for 10 min on ice and for 50 min at 37~ Finally, the cells were washed twice and suspended in medium.
Southern Blots. DNA was prepared from frozen organs (liver, lung, kidney, and spleen) following published protocols (29) . 2-10 Ixg of undigested DNA or DNA cut with EcoRI, which cuts the PyV genome once, was subjected to electrophoresis in 0.8% agarose gels, and transferred to nitrocellulose paper by vacuum blotting (30), or to nylon transfer membrane (Magna Charge; Micron Separations Inc., Westboro, MA) by capillary transfer. The DNA blot was then baked, prehybridized, hybridized, washed, and exposed to autoradiography as described (31) . PyV strain A2 cloned in pAT153 plasmid was kindly provided by Dr. Michele M. Fluck, and it was 32p-labeled by random priming for use as a hybridization probe.
Immunofluorescent Staining. NIH 3T3 clone A31 cells were seeded on microscope glass coverslips and infected with PyV strain A2. On day 3 after infection, the cells on the coverslips were fixed for 10 rain with a 1 : 1 mixture of ethanol and ethylether, followed by 20 rain in 95% ethanol. Staining was performed in a humid chamber for 35 rain at room temperature with dilutions of sera from PvY-infected immunocompetent or cx13 knockout mice or of normal (uninfected) mouse serum. The coverslips were subsequently rinsed with PBS and incubated for 35 rain with FITC-labeled antibodies specific for mouse IgM (IX chain), IgG (~/ chain) (Vector Laboratories, Inc., Burlingame, CA), IgG1, IgG2a, IgG2b, and IgG3 (Zymed Laboratories, Inc., San Francisco, CA). The coverslips were rinsed with PBS, mounted on microscope slides with 90% glycerol/10% PBS, and viewed by fluorescence microscopy.
Purification of IgG from PyV-infected oefl Knockout Mouse Serum.
A protein A-Sepharose CL-4B (Pharmacia Biotech, Piscataway, NJ) column was prepared according to the manufacturer's instructions and washed with 0.1 M Tris-HC1, pH 8.0 (binding buffer). A 0.5-ml sample of pooled serum harvested on day 14 after PyV infection of o~13 knockout mice was mixed with 50 p,1 I M Tris-HC1, pH 8.0, loaded on the column, and washed with binding buffer (10• column volume). The IgG fraction was eluted by 0.1 M citric acid, pH 3.0. To preserve the activity of acid-labile IgG, each collected fraction (0.5 ml) was neutralized by the addition of 50 IXl 1 M Tris-HC1, pH 9.0. The protein content of the fractions was determined by an OD 280 reading, and the PyVspecific IgG content by indirect fluorescent staining. (17) . The fact that this pathology was very different from the tumor induction described in nude mice indicated that B cells and/or extrathymically developing T cells might have an important role in PyV pathogenesis. To address this question, we infected mice having various T and/or B cell deficiencies with PyV ( Table 1) .
Results

Outcome of P y V Infection in Mice Deficient in T and~or
Mice that had a targeted disruption in the TClk ot or 13 gene (ct13 knockout mice) (24) survived the acute phase of PyV infection and did not show any symptoms of the AMD up until 3 mo after infection. Depletion of the TClk or13 knockout mice of NK cells in vivo by anti-NKl.1 antibodies did not influence this outcome. Mice deficient in both 0tl3 and ~/g T cells (22) also survived, regardless of the presence or absence of NK cells. Two of three ct13 knockout mice and one of four NK-depleted ct13 knockout mice had to be killed between day 28 and 69 after infection, because the animals had gastrointestinal obstruction or serious wasting associated with diarrhea. These symptoms were consistent with an ulcerative cohtishke pathology that is known to affect this mutant mouse strain (32) . Therefore, we consider the death of these animals not PyV related.
Mice deficient in functional B cells due to a targeted disruption of the Ig Ix chain gene (Ix-/-) (23) were also resistant to the PyV-induced acute myeloproliferation. However, when these Ix-/-mice were depleted in vivo of CD4 + and CD8 + T ceils by combined injections with anti-CD4 and anti-CD8 antibodies, the animals (three of three) died of AMD by day 16 
Prevention of PyV-induced AMD by Adoptive Transfer of B Cells into SCID Mice.
To further investigate the role of different cell populations of the immune system in the resistance to PyV infection, adoptive transfer experiments were performed (Table 2 ). Spleen cells were prepared from uninfected, immunocompetent BALB/c mice. This cell population was used directly for adoptive transfer, or was first depleted ofT cells in vitro by lysing the cells with antiThy-1 antibody and complement. The success of the depletion was monitored by FACS | staining. Splenocytes from ot13 T cell knockout mice, B cell knockout mice, and B cell knockout mice after T cell depletion were also used for adoptive transfer into SCID mice. Adoptive transfer of the total spleen cell population (T and B ceils) protected SCID mice not only from AMD, but from later tumor induction as well. All mice receiving B cells (Thy-l-depleted splenocytes, or spleen cells from ct13 knockout mice) were protected from the AMD, but in a fraction of these ani- (17, 20) . W e asked whether the protection of SCID mice from the A M D by B cells was associated with a major decrease in the amount of the virus in different organs. SCID mice, SCID mice adoptively transferred with B cells (Thy-1-depleted splenocytes) or with B and T cells (undepleted spleen cells) were infected with PyV and killed at days 3, 7, and 14 after infection. The presence of viral genome in D N A samples prepared from spleen, kidney, liver, and lung tissues of the animals was analyzed by Southern blots, using cloned, 32p-labeled PyV A2 genome as the hybridization probe. At day 3, all three groups of mice had viral signal in the spleen (Fig. 1 A) . At this time D N A samples from other organs (kidney, lung, and liver) did not show the presence of viral genome, even after a long exposure of the blots (kidney and lung not shown). At day 7, strong viral bands could be observed in all four organs in SCID mice, a finding consistent with our previous results (17) . In SCID mice adoptively transferred with B cells alone, or with B and T cells, very little or no virus-specific D N A was detected in any of the organs tested. Even in the spleen the viral signal, which could be observed at day 3, was largely diminished by day 7 (Fig. 1 /3 ). At day 14, whereas PyV could be detected in all four organs in SCID mice, the virus signal was absent from SCID mice receiving B cells or T and B cells ( Fig. 1 C and Fig. 2/3 ). The fact that we could not observe significant differences in the efficiency o f PyV clearance in the spleen, kidneys, liver, or lung by B cells alone or by T and B cells together at day 7 and 14 after infections indi- 5, 9 cates that B cells could control PyV rephcation in these organs in the absence o f T cells.
Protection Against A M D Is Mediated by Serum. We tested whether serum from PyV-infected ct[3 knockout mice could transfer protection to SCID mice against PyV-induced AMD. ot[3 knockout mice and C57BL/6 mice were infected with PyV; 7 d after infection, the mice were bled and serum was harvested. C.B17 SCID mice were then injected with the sera 1 d before PyV infection. Sera from normal, uninfected mice were used as negative controls. Sera from PyV-infected C57BL/6 mice or ot[3 knockout mice prolonged the survival o f the SCID mice, regardless of the route of injection (i.p. or i.v.) (Table 3) . Sera from uninfected mice did not have any effect on survival. The mice that received "PyV-immune" sera died between day 37 and 48 after infection with the pathological signs of AMD. This indicates that a single injection of serum could not completely prevent but could delay the lethal outcome by 3-4 wk; the same 3 -4 -w k delay in the onset o f A M D was observed when serum harvested at day 14 after PyV infection ofot[3 knockout mice was used ( Table 4 ). The prolonged survival was accompanied by a delay in the kinetics of virus rephcation (Fig. 2) . In SClD mice treated with day 7 serum of PyV-infected ot[3 T cell-deficient mice, no viral D N A could be detected by Southern blots at day 4 and 14 after PyV infection, although by this time in untreated SCID mice, high levels of PyV replication could be observed in all organs tested. However, by day 32, the PyV genome became readily detectable in samples of spleen, kidney, hver, and lung D N A from the PyV-immune serum-treated SCID mice (data from two individual mice are shown in Fig. 2) .
Serum of Py V-infected T Cell-deficient Mice Contains Virusspecific IgM and IgG.
To determine whether serum derived from PyV-infected cx[3 knockout mice at day 14 after infection contains PyV-specific IgM or IgG antibodies, indirect immunofluorescent staining experiments were performed. 3T3 cells infected with PyV for 3 d were reacted with a 1:20 dilution of the serum, followed by staining with FITC-conjugated murine IX chain-or murine y chain-specific second antibody. Bright nuclear fluorescent staining o f the PyVinfected cells could be observed with the y chain~specific reagent (Fig. 3 A) . This staining was specific, because PyVinfected cells exposed to non-PyV-immune serum and the anti-y-FITC antibody exhibited only diffuse, cytoplasmic background fluorescence (Fig. 3 B. ). Using PyV-immune ot13 knockout serum with FITC-antimurine Ix antibody, a virus-specific nuclear fluorescent signal was also observed, indicating that T cell-deficient mice mount virus-specific IgM and IgG responses against PyV. Immunofluorescent PyV-infected T C R Ix[3-/-~ 200 txl i.v. 48 (2) AMD *Mice were killed moribund on the indicated day. Moribund mice had milled fur, pale ear color, and hunched posture, and would be expected to die within 24 h according to our previous experiments. *Standard deviation. ~Serum was harvested at day 7 after infection. IINumber of mice. Tables 1 and 3) . ItSemm was harvested on day 14 after infection. 82 mouse died on day 39, the other was killed with no symptoms. **Peak I chromatography fraction contained both IgM and IgG. **Peak I fraction showed positive IgG-specific fluroescence undiluted, but in 1:20 dilution was negative. ~Peak II chromatography fraction contained only IgG. ImlgG-containing fractions of ot[3 knockout mouse serum harvested 14 d after PyV infection were obtained by chromatography on a protein A-Sepharose column (see Materials and Methods).
staining of PyV-infected 3T3 cells with serum of PyVinfected ot[3 knockout mice (1:20 dilution) and FITClabeled second antibodies specific for subclasses of IgG revealed that the serum of PyV-infected ot[3 knockout mice contained predominantly IgG2a, as IgGl-, IgG2b-, and IgG3-specific staining was not detectable. However, bright nuclear fluorescence was observed with the anti-IgG2a-FITC antibody. Sera from PyV-infected, NK-depleted oL[3~/8 knockout mice harvested 2 wk after infection also contained levels of IgG2a comparable to those of the PyVinfected cx[3 knockout mouse serum. Staining with a 1:100 dilution of this sera and IgG2a-specific FITC-labeled antibodies resulted in bright nuclear fluorescence of PyV-infected cells (not shown).
To test whether purified IgM or IgG fractions of PyVinfected ot[3 knockout mice can protect SCID mice against the acute PyV-induced disease, the serum was fractionated by chromatography on a Sephacryl 300 (Pharmacia Biotech, Uppsala, Sweden) column. The first protein peak eluted from the column was enriched for IgM, but contained IgG as well. The second protein peak contained IgG, but no detectable IgM. SCID mice injected with 200 lxl of either fraction survived PyV infection significantly longer than SCID mice treated with sera of naive knockout mice before infection (Table 4 (Table 4) .
Discussion
We show here that B cells in the absence of T cells protect mice from PyV-induced lethal AMD. This protection is mediated by the induction of PyV-specific IgM and IgG antibodies, predominantly IgG2a, produced without any T cell help. These antibodies then dear PyV in different organs of the PyV-infected mice. To our knowledge, this is the first example of a completely T ceLl-independent antibody response effectively reducing virus load ("clearance") and thereby dramatically changing the outcome of a virus infection (from 100% lethality by day 16 to 100% survival).
It is well known that virus-specific antibodies can prevent infection or reinfection by neutralization (33) , and several studies have indicated that antibodies are also capable of mediating virus clearance in vivo. Examples of this are reovirus and Sindbis virus clearance in the central nervous system of neonatal or SCID mice by the injection of monoclonal antibodies (8, 34) , or influenza virus clearance by transfer of monoclonal antibodies into SCID mice (35) . However, the generation of an efficient, high-affinity antibody response and the switching from IgM to IgG or IgA production usually requires T cell help (4, 5) . It is very interesting therefore, that PyV is an inducer of a protective antibody response in T cell-deficient mice. In PyVinfected SCID mice, the virus replicates to high levels, and the high level of virus antigens might be an important requirement for triggering T cell-independent antibody production. This is also suggested by a recent publication by Freer et al. (36) , which reported induction of VSV-specific IgG in nude mice. In that system, the T cell dependence of both IgG and, to a lesser degree, IgN1, seemed to be dependent on the antigen dose, and only at very high antigen levels of UV-inactivated VSV was an "inefficient but significant" switch to IgG synthesis observed. However, since nude mice are not completely free o f T cells, the possibility of helper factors produced by the remaining T cells was not excluded in those experiments.
It is interesting to speculate which factors might contribute to the efficient switch from IgM to lgG production in the absence of any T cell help (and even in the absence of NK cells) in the case of PyV infection. One factor in overcoming the lack of usual helper functions might be a characteristic feature of the antigen. The major capsid glycoprotein PyV, VP1, is repeated periodically 360 times (in 72 pentamers) in the virion capsid structure (37, 38) . T cellindependent antigens typically consist of multiple repeating epitopes that allow for extensive cross-linking of the antigen receptor on the B cell surface. Most T cell-independent antigens are polysaccharides, but polymeric protein structures with repetitive epitopes, such as bacterial flagellin, can be T cell-independent antigens as well (39, 40) . Therefore, the structural periodicity of the PyV virion capsids might be responsible, at least in part, for the ability to trig-
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Tsuda and Welsh ger T cell-independent antibody responses. This idea is supported by a report by Bachmann et al. (41) , which describes that transgenic mice tolerant to nonrepetitive VSV glycoprotein antigen produced antibodies in response to the highly organized, repetitive form of the same antigen represented by formalin-inactivated virions. Therefore, the organization and density of antigenic epitopes had an important role in determining B cell induction. However, since many viruses have capsids with similar (icosahedral) repetitive structures, it is surprising that T cell-independent antibody responses influencing the pathogenesis of other virus infections have not been reported so far. The newly available mouse strains with complete and selective T cell deficiencies will be useful for determining how widespread this phenomenon is. Other factors in PyV-infected T celldeficient mice, such as the production of cytokines, may also contribute to the induction of a strong T cell-independent antibody response. Because the serum from PyV-infected 0tl3 knockout mice has some neutralizing activity in vitro (preliminary data, not shown), neutralization of PyV would be an obvious mechanism of action of the antiviral antibodies. H o wever, the protective effects of antibodies in vivo do not necessarily correlate with their in vitro neutralizing abilities (42--44) . Both neutralizing and nonneutralizing antibodies can clear Sindbis virus in the infected central nervous system. In this case, viral protein synthesis and virus assembly are inhibited by the antibodies, which bind to the membrane of the virus-infected cells (8) . In LCMV infection, reduction of viral titers in tissues is mediated by some, but not all neutrahzing antibodies. It is interesting to note that antibodies with IgG2a isotype are the best at protecting against LCMV (43) , and that this isotype was shown to be a major component in the sera ofPyV-infected, T cell-deficient mice. IgG2a is known to be predominantly produced in response to virus infections in general, and to PyV infection in particular, in immunocompetent mice (45) . It is surprising, however, that this happens even in the absence of T cells after PyV infection.
In summary, our results show that PyV can behave as a T cell-independent antigen and provide the first unambigous example we know of a virus inducing a physiologically relevant, T cell-independent antibody response that can control the infection.
